NHS officials in England have made an improved two-year pricing deal to Vertex Pharmaceuticals in a bid to give patients access to cystic fibrosis (CF) medicines. John Stewart, national director of specialised commissioning for NHS England outline...
Original Article: NHS England improves offer to Vertex over CF drugs